| Line Item | 2024-05-26 | Y/Y |
|---|---|---|
| Revenue | $6.47B | +20.9% |
| Cost of Revenue | $4.70B | +20.0% |
| Gross Profit | $1.77B | +23.4% |
| R&D Expense | $26.4M | +53.5% |
| SG&A Expense | $701.4M | +27.5% |
| Operating Income | $1.07B | +20.8% |
| Pre-tax Income | $955.5M | -22.5% |
| Income Tax | $230.0M | +2.4% |
| Net Income | $725.5M |
| Line Item | 2024-05-26 | Y/Y |
|---|---|---|
| Cash & Equivalents | $71.4M | -76.6% |
| Accounts Receivable | $743.6M | +2.7% |
| Inventory | $1.14B | +22.2% |
| Current Assets | $2.09B | -1.7% |
| Total Assets | $7.37B | +13.0% |
| Current Liabilities | $1.62B | +19.4% |
| Long-term Debt | $3.84B | +18.1% |
| Line Item | 2024-05-26 | Y/Y |
|---|---|---|
| Operating Cash Flow | $798.2M | +4.8% |
| Capital Expenditures | $929.5M | +42.1% |
| Investing Cash Flow | -$984.1M | +26.6% |
| Financing Cash Flow | -$48.0M | -114.1% |
| Free Cash Flow | -$131.3M | -221.9% |
| -28.1% |
| EPS (Basic) | $5.01 | -28.2% |
| EPS (Diluted) | $4.98 | -28.3% |
| Stockholders' Equity |
| $1.79B |
| +26.7% |